Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortic Coarctation | 2 | 2023 | 36 | 0.900 |
Why?
|
| Tetralogy of Fallot | 2 | 2020 | 44 | 0.820 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2021 | 64 | 0.770 |
Why?
|
| Pulmonary Atresia | 1 | 2020 | 12 | 0.730 |
Why?
|
| Education, Distance | 1 | 2020 | 25 | 0.730 |
Why?
|
| Heart Defects, Congenital | 4 | 2022 | 363 | 0.690 |
Why?
|
| Cardiology | 1 | 2020 | 114 | 0.680 |
Why?
|
| Chloral Hydrate | 1 | 2019 | 3 | 0.670 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 120 | 0.670 |
Why?
|
| Pentobarbital | 1 | 2019 | 20 | 0.670 |
Why?
|
| Angioplasty, Balloon | 1 | 2019 | 96 | 0.660 |
Why?
|
| Conscious Sedation | 1 | 2019 | 67 | 0.640 |
Why?
|
| Echocardiography | 3 | 2023 | 936 | 0.610 |
Why?
|
| Hypnotics and Sedatives | 1 | 2019 | 131 | 0.600 |
Why?
|
| Systemic Inflammatory Response Syndrome | 3 | 2021 | 51 | 0.580 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2020 | 473 | 0.570 |
Why?
|
| Education, Medical, Graduate | 1 | 2020 | 390 | 0.550 |
Why?
|
| Stents | 1 | 2019 | 395 | 0.550 |
Why?
|
| Pediatrics | 1 | 2020 | 351 | 0.550 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2015 | 161 | 0.530 |
Why?
|
| Pulmonary Artery | 2 | 2013 | 318 | 0.470 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2013 | 41 | 0.440 |
Why?
|
| Child | 8 | 2022 | 7112 | 0.370 |
Why?
|
| Heart Bypass, Right | 1 | 2010 | 12 | 0.360 |
Why?
|
| Fontan Procedure | 1 | 2010 | 56 | 0.350 |
Why?
|
| Infant | 4 | 2021 | 3130 | 0.350 |
Why?
|
| Child, Preschool | 5 | 2022 | 3695 | 0.320 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2021 | 328 | 0.310 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2023 | 3441 | 0.270 |
Why?
|
| Retrospective Studies | 8 | 2023 | 8960 | 0.240 |
Why?
|
| Humans | 19 | 2023 | 88835 | 0.210 |
Why?
|
| Endocarditis | 1 | 2022 | 21 | 0.210 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2021 | 27 | 0.200 |
Why?
|
| Predictive Value of Tests | 2 | 2023 | 1712 | 0.200 |
Why?
|
| Coronary Aneurysm | 1 | 2021 | 16 | 0.200 |
Why?
|
| Churg-Strauss Syndrome | 1 | 2021 | 9 | 0.190 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 10 | 0.180 |
Why?
|
| Azithromycin | 1 | 2020 | 13 | 0.180 |
Why?
|
| Collateral Circulation | 1 | 2020 | 35 | 0.180 |
Why?
|
| Long QT Syndrome | 1 | 2020 | 36 | 0.180 |
Why?
|
| Female | 12 | 2023 | 45893 | 0.180 |
Why?
|
| Needs Assessment | 1 | 2020 | 157 | 0.170 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2020 | 197 | 0.160 |
Why?
|
| Thrombosis | 1 | 2021 | 302 | 0.150 |
Why?
|
| Male | 10 | 2023 | 42127 | 0.150 |
Why?
|
| Electrocardiography | 1 | 2020 | 493 | 0.150 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 704 | 0.140 |
Why?
|
| Gadolinium | 1 | 2017 | 103 | 0.140 |
Why?
|
| Sarcoidosis | 1 | 2017 | 72 | 0.140 |
Why?
|
| Immunotherapy | 1 | 2021 | 664 | 0.130 |
Why?
|
| Curriculum | 1 | 2020 | 567 | 0.130 |
Why?
|
| Computer Systems | 1 | 2015 | 79 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 319 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 304 | 0.120 |
Why?
|
| Age Factors | 1 | 2019 | 1862 | 0.120 |
Why?
|
| Cardiomyopathies | 1 | 2017 | 263 | 0.120 |
Why?
|
| Aorta, Thoracic | 1 | 2015 | 166 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 770 | 0.120 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2013 | 12 | 0.120 |
Why?
|
| Young Adult | 5 | 2023 | 6271 | 0.120 |
Why?
|
| Pulmonary Valve | 1 | 2013 | 34 | 0.110 |
Why?
|
| Infant, Newborn | 1 | 2019 | 2464 | 0.110 |
Why?
|
| India | 2 | 2011 | 123 | 0.110 |
Why?
|
| Adolescent | 5 | 2022 | 9201 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2022 | 2647 | 0.110 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 2607 | 0.100 |
Why?
|
| Exercise | 1 | 2015 | 322 | 0.100 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2013 | 136 | 0.100 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2013 | 178 | 0.100 |
Why?
|
| Chest Tubes | 1 | 2010 | 23 | 0.090 |
Why?
|
| Developing Countries | 1 | 2011 | 76 | 0.090 |
Why?
|
| Pleural Effusion | 1 | 2010 | 47 | 0.090 |
Why?
|
| Exercise Tolerance | 1 | 2010 | 52 | 0.090 |
Why?
|
| Warfarin | 1 | 2010 | 104 | 0.090 |
Why?
|
| Drainage | 1 | 2010 | 159 | 0.080 |
Why?
|
| Aspirin | 1 | 2010 | 159 | 0.080 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2010 | 143 | 0.080 |
Why?
|
| Algorithms | 1 | 2017 | 1870 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 780 | 0.080 |
Why?
|
| Adult | 6 | 2023 | 26437 | 0.080 |
Why?
|
| Ventricular Function, Left | 2 | 2021 | 602 | 0.070 |
Why?
|
| Anticoagulants | 1 | 2010 | 425 | 0.070 |
Why?
|
| Blood Pressure | 1 | 2010 | 898 | 0.070 |
Why?
|
| Oxygen | 1 | 2010 | 742 | 0.060 |
Why?
|
| Time Factors | 2 | 2011 | 5311 | 0.060 |
Why?
|
| Aorta | 1 | 2023 | 286 | 0.050 |
Why?
|
| Cardiotoxicity | 1 | 2021 | 10 | 0.050 |
Why?
|
| Aortic Valve | 1 | 2023 | 243 | 0.050 |
Why?
|
| Myocarditis | 1 | 2021 | 51 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2011 | 8177 | 0.050 |
Why?
|
| Heart Neoplasms | 1 | 2021 | 63 | 0.050 |
Why?
|
| New York City | 1 | 2020 | 61 | 0.050 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2022 | 346 | 0.050 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 76 | 0.040 |
Why?
|
| Coronary Vessels | 1 | 2021 | 190 | 0.040 |
Why?
|
| Anti-Infective Agents | 1 | 2020 | 91 | 0.040 |
Why?
|
| Heart | 1 | 2021 | 573 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 1066 | 0.040 |
Why?
|
| Middle Aged | 3 | 2023 | 25783 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 261 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 1590 | 0.030 |
Why?
|
| Prognosis | 1 | 2023 | 3756 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 1591 | 0.030 |
Why?
|
| Pregnancy | 1 | 2023 | 3002 | 0.030 |
Why?
|
| Risk Factors | 2 | 2020 | 5447 | 0.030 |
Why?
|
| Aged | 2 | 2023 | 19014 | 0.030 |
Why?
|
| Biopsy | 1 | 2017 | 1180 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2015 | 778 | 0.030 |
Why?
|
| Radiography | 1 | 2013 | 809 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 360 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 2410 | 0.020 |
Why?
|
| Reoperation | 1 | 2011 | 598 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2011 | 352 | 0.020 |
Why?
|
| Critical Care | 1 | 2011 | 380 | 0.020 |
Why?
|
| Length of Stay | 1 | 2011 | 732 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2011 | 2285 | 0.010 |
Why?
|